For Korean pharmaceutical products to compete in overseas markets, the nation must urgently improve its drug pricing system by, for instance, assigning appropriate values to new drugs, experts said.They added that the industry must also raise the self-sufficiency rate of homegrown active pharmaceuti
Ildong Pharmaceutical said on Wednesday that it will separate its research and division (R&D) department and establish a subsidiary to boost profitability and R&D.Ildong Pharmaceutical will maintain a 100 percent stake in the new company as the parent company. The tentative name of the corporation i
Korea's healthcare industry is doubling efforts to support participants of the 25th World Scout Jamboree, although its organizers were heavily criticized for disorganization and unpreparedness.Most recently, Daewoong Co. said that it has fully opened its human resource development (HRD) training cen
Human immunodeficiency virus (HIV) is no longer a death sentence to patients as anti-retroviral therapy (ART), the treatment used to suppress the virus in people living with HIV, has improved dramatically over the past 40 years, making HIV a manageable chronic disease.Reflecting this, a study found
On July 17, the American supercentenarian, Louise Levy, died at the age of 112. Levy was one of more than 700 people who were part of a study on the relationship between longevity and genetics, so her demise has garnered extensive coverage across the global media landscape. The number of centenarian
EONE-Diagnomics Genome Center (EDGC) said on Thursday that it formed a task force for the Cancer Moonshot project and is in discussions with the CancerX team about joining as a member with its companion diagnostic (CDx) liquid biopsy, ONCOCATCH.EONE-Diagnomics Genome Center is a joint venture betwee
More than one million Koreans are living with cancers as survival rates have improved thanks to the development of early detection, surgical treatment, and a variety of effective cancer therapies.While the cancer treatment has improved, a St. Mary's Seoul Hospital team, led by Professors Jung Mi-hya
The National Health Insurance Service (NHIS) has published a study in an international journal, finding its long-term care family counseling support project, “COMPASS,” beneficial to the health of family caregivers of long-term care recipients.The NHIS said Wednesday that the findings were based on
An advanced practice nurse, who performed a periosteal puncture to collect bone marrow under the guidance and supervision of a physician at Asan Medical Center (AMC), has been convicted of conducting an unlicensed medical act by a local court.The decision overturned a lower court ruling that had fou
Canon Medical Systems Korea is voluntarily recalling all Vantage Galan 3T MODEL MRT-3020 MRI units installed in Korea after one of the devices in use in Japan caught fire during operations.According to the Ministry of Food and Drug Safety, the incident happened at a hospital in Japan when an operato
Palatin Technologies, a U.S. pharmaceutical company, said that Kwangdong Pharmaceutical, its Korean partner, has nearly completed a phase 3 clinical trial in Korea for Vyleesi (ingredient: bremelanotide), a hypoactive sexual desire disorder (HSDD) treatment for women. Kwangdong licensed in Vyleesi i
Lotte Biologics said on Wednesday that it signed a memorandum of understanding (MOU) with Roche Diagnostics to advance its contract development and manufacturing (CDMO) business. Last month, Lotte Biologics signed a four-way memorandum of understanding (MOU) with Lotte Holdings, Incheon Metropolitan
Huons recorded its best performance ever in the second quarter this year.The company released its second-quarter performance in a public filing Tuesday.On a consolidated basis, Huons reported second-quarter revenue of 140.7 billion won ($106.5 million), operating income of 17.9 billion won, and net
Hanmi Pharm’s nonalcoholic steatohepatitis (NASH) drug candidate, efinopegdutide (HM12525A), licensed out to MSD, is increasingly likely to emerge as a best-in-class treatment thanks to organic collaboration between the two partners.At a workshop co-organized by MSD Korea and the Korean Health Indus
SK bioscience said on Wednesday that it made an equity investment in Novavax, a U.S. vaccine maker, paying $85 million (approximately 112 billion won) to secure 6.5 million shares of common stock through a private placement, equating to a 7 percent stake in the company.Due to weakening demand for it
A researcher at Ajou University Hospital has identified that patients with alopecia areata, also known as circular hair loss, have worse symptoms if the patient is aged 15 or younger or the bold spot covers more than half of the scalp.Alopecia areata is an autoimmune disorder in which cytotoxic T-ce
Health experts highlighted Korea’s conservative view towards telemedicine, stressing the need to conduct further pilot projects to move the telemedicine industry forward.The Korean Telemedicine Industry Council (KTIC) held a symposium inviting foreign and local medical industry experts to comment on
In a step toward restructuring the overconcentration of hospital beds in Seoul and neighboring cities, the government has announced a plan to restrain the growth of bed supply in regions where there is already an excessive number of beds compared to the local population and demand.Starting next year
Korea Biomedical Review is publishing a series of articles to analyze the top 10 Korean pharmaceutical and biopharma companies with the largest market capitalizations listed on the main bourse, Kospi, and the tech-heavy Kosdaq. The series aims to reflect key industrial issues and the flow of the cap
Daewon Pharmaceutical has taken the first step toward conducting clinical trials to develop a semaglutide-based obesity treatment as a patch.Daewon Pharm and Raphas said Tuesday they had completed the investigational new drug application for a phase 1 clinical trial of DW-1022, a microneedle patch o